Bank of New York Mellon Corp acquired a new position in shares of Intrexon Corp. (NYSE:XON) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 215,833 shares of the company’s stock, valued at approximately $5,312,000. Bank of New York Mellon Corp owned about 0.18% of Intrexon Corp. at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of XON. Public Employees Retirement Association of Colorado raised its position in shares of Intrexon Corp. by 1.8% in the second quarter. Public Employees Retirement Association of Colorado now owns 12,085 shares of the company’s stock valued at $297,000 after buying an additional 209 shares during the period. Sanders Morris Harris Inc. raised its position in shares of Intrexon Corp. by 93.6% in the second quarter. Sanders Morris Harris Inc. now owns 85,000 shares of the company’s stock valued at $2,092,000 after buying an additional 41,100 shares during the period. Cacti Asset Management LLC bought a new position in shares of Intrexon Corp. during the second quarter valued at approximately $246,000. Legal & General Group Plc raised its position in shares of Intrexon Corp. by 3.4% in the first quarter. Legal & General Group Plc now owns 3,788 shares of the company’s stock valued at $128,000 after buying an additional 126 shares during the period. Finally, Cupps Capital Management LLC bought a new position in shares of Intrexon Corp. during the first quarter valued at approximately $1,368,000. 84.05% of the stock is owned by institutional investors and hedge funds.
Shares of Intrexon Corp. (NYSE:XON) traded down 2.25% on Friday, hitting $27.41. 860,977 shares of the stock traded hands. The stock’s market cap is $3.24 billion. Intrexon Corp. has a 12-month low of $18.52 and a 12-month high of $45.90. The stock has a 50-day moving average price of $27.36 and a 200 day moving average price of $28.74.
Intrexon Corp. (NYSE:XON) last announced its earnings results on Tuesday, August 9th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.16. Intrexon Corp. had a negative return on equity of 19.00% and a negative net margin of 96.65%. The firm earned $52.50 million during the quarter, compared to analyst estimates of $53.78 million. During the same quarter in the previous year, the business earned ($0.37) earnings per share. The business’s quarterly revenue was up 17.0% compared to the same quarter last year. On average, analysts anticipate that Intrexon Corp. will post ($1.36) earnings per share for the current fiscal year.
Several equities analysts recently commented on XON shares. Griffin Securities reaffirmed a “buy” rating and set a $65.00 price target on shares of Intrexon Corp. in a research report on Tuesday, June 7th. Stifel Nicolaus reaffirmed a “buy” rating and set a $57.00 price target on shares of Intrexon Corp. in a research report on Wednesday, June 29th. Wunderlich reissued a “buy” rating and issued a $50.00 price objective on shares of Intrexon Corp. in a research report on Thursday, July 7th. JMP Securities reissued a “buy” rating on shares of Intrexon Corp. in a research report on Sunday, July 17th. Finally, Zacks Investment Research raised shares of Intrexon Corp. from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a research report on Tuesday, July 19th. Three research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $41.71.
In related news, SVP Nir Nimrodi purchased 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 29th. The stock was acquired at an average cost of $26.12 per share, for a total transaction of $104,480.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 55.10% of the company’s stock.
About Intrexon Corp.
Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.
Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corp. (NYSE:XON).
Receive News & Ratings for Intrexon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corp. and related companies with MarketBeat.com's FREE daily email newsletter.